154 related articles for article (PubMed ID: 11764088)
1. Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes.
Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Yarasheski KE; Smith SR; Lang HJ; Williamson JR; Ido Y
J Neuropathol Exp Neurol; 2001 Dec; 60(12):1153-69. PubMed ID: 11764088
[TBL] [Abstract][Full Text] [Related]
2. A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Yarasheski KE; Smith SR; Williamson JR; Peterson RG; Oates PJ
Exp Neurol; 2005 Apr; 192(2):407-19. PubMed ID: 15755558
[TBL] [Abstract][Full Text] [Related]
3. Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Williamson JR; Ido Y
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1175-89. PubMed ID: 9862641
[TBL] [Abstract][Full Text] [Related]
4. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
5. Effect of NGF and neurotrophin-3 treatment on experimental diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Escandon E
J Neuropathol Exp Neurol; 2001 Mar; 60(3):263-73. PubMed ID: 11245210
[TBL] [Abstract][Full Text] [Related]
6. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Zhang W; Sima AA
J Neuropathol Exp Neurol; 2004 May; 63(5):450-60. PubMed ID: 15198124
[TBL] [Abstract][Full Text] [Related]
7. Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes.
Schmidt RE; Dorsey DA; Beaudet LN; Reiser KM; Williamson JR; Tilton RG
Diabetes; 1996 Mar; 45(3):284-90. PubMed ID: 8593931
[TBL] [Abstract][Full Text] [Related]
8. Effects of sorbinil, dietary myo-inositol supplementation, and insulin on resolution of neuroaxonal dystrophy in mesenteric nerves of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Coleman BD; Williamson JR; Tilton RG
Diabetes; 1991 May; 40(5):574-82. PubMed ID: 1902427
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
Cameron NE; Cotter MA; Basso M; Hohman TC
Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
[TBL] [Abstract][Full Text] [Related]
10. [Diabetic neuropathies. Metabolism of sorbitol in sciatic nerve tissue in streptozotocin diabetes].
Kryvko IuIa; Kozyts'kyĭ ZIa; Serhiienko OO; Kuchmerovs'ka TM; Velykyĭ MM
Ukr Biokhim Zh (1999); 2001; 73(5):69-74. PubMed ID: 12035507
[TBL] [Abstract][Full Text] [Related]
11. Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor.
Obrosova IG; Fathallah L; Lang HJ
Biochem Pharmacol; 1999 Dec; 58(12):1945-54. PubMed ID: 10591149
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine hydroxylase activity in sympathetic nervous system of rats with streptozocin-induced diabetes.
Schmidt RE; Cogswell BE
Diabetes; 1989 Aug; 38(8):959-68. PubMed ID: 2568957
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural and biochemical characterization of autonomic neuropathy in rats with chronic streptozotocin diabetes.
Schmidt RE; Plurad SB
J Neuropathol Exp Neurol; 1986 Sep; 45(5):525-44. PubMed ID: 3746343
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Peterson RG
Am J Pathol; 2003 Jul; 163(1):21-8. PubMed ID: 12819007
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic autoimmune nerve growth factor deprivation on sympathetic neuroaxonal dystrophy in rats.
Schroer JA; Beaudet LN; Schmidt RE
Synapse; 1995 Jul; 20(3):249-56. PubMed ID: 7570357
[TBL] [Abstract][Full Text] [Related]
16. Experimental diabetic autonomic neuropathy characterization in streptozotocin-diabetic Sprague-Dawley rats.
Schmidt RE; Plurad SB; Modert CW
Lab Invest; 1983 Nov; 49(5):538-52. PubMed ID: 6632773
[TBL] [Abstract][Full Text] [Related]
17. Anticataract activity of analogs of a sorbitol dehydrogenase inhibitor.
Kador PF; Inoue J; Blessing K
J Ocul Pharmacol Ther; 2004 Aug; 20(4):333-44. PubMed ID: 15321028
[TBL] [Abstract][Full Text] [Related]
18. Ganglion-specific patterns of diabetes-modulated gene expression are established in prevertebral and paravertebral sympathetic ganglia prior to the development of neuroaxonal dystrophy.
Carroll SL; Byer SJ; Dorsey DA; Watson MA; Schmidt RE
J Neuropathol Exp Neurol; 2004 Nov; 63(11):1144-54. PubMed ID: 15581182
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats.
Tilton RG; Chang K; Nyengaard JR; Van den Enden M; Ido Y; Williamson JR
Diabetes; 1995 Feb; 44(2):234-42. PubMed ID: 7859946
[TBL] [Abstract][Full Text] [Related]
20. Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Frederick KE; Parvin CA; Plurad SB; Levisetti MG
Am J Pathol; 2003 Nov; 163(5):2077-91. PubMed ID: 14578206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
